Novel 3-hydroxy-3-phenylpropanoate ester–azidothymidine (AZT) conjugates have been prepared using Baylis–Hillman methodology, and their potential as dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors has been explored using enzyme inhibition and computer modelling techniques; their activity and HeLa cell toxicity have been compared with those of their cinnamate ester analogues.
使用Baylis-Hillman方法制备了新型3-羟基-
3-苯基丙酸酯-
叠氮胸苷(AZT)共轭物,并通过酶抑制和计算机建模技术探索了其作为HIV-1双重作用和逆转录酶
抑制剂的潜力。它们的活性和HeLa细胞毒性已与
肉桂酸酯类似物进行了比较。